Rafferty Asset Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,422
Closed -$4.31M 1279
2021
Q1
$4.31M Buy
25,422
+21,751
+593% +$4.58M 0.03% 318
2020
Q4
$746K Buy
+3,671
New +$710K 0.01% 593
2020
Q3
Sell
-790
Closed -$216K 1049
2020
Q2
$216K Buy
+790
New +$211K ﹤0.01% 911
2020
Q1
Sell
-970
Closed -$361K 822
2019
Q4
$361K Sell
970
-1,029
-51% -$295K 0.01% 752
2019
Q3
$651K Sell
1,999
-129
-6% -$43.9K 0.01% 617
2019
Q2
$750K Buy
+2,128
New +$836K 0.01% 615

Other funds holding QTTB

Rafferty Asset Management's QTTB Position: Q2 2021 in Review

Rafferty Asset Management sold out of Q32 Bio (QTTB) in Q2 2021, closing a stake of 25,422 shares — an estimated $4.31M sold.

Rafferty Asset Management first reported a position in QTTB in Q2 2019 and held it in 6 quarters. The position peaked at $4.31M in Q1 2021. 118 funds tracked by Wall St. Rank hold QTTB as of Q2 2021.

  • Rafferty Asset Management reported no remaining Q32 Bio position as of Q2 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 25,422 Q32 Bio shares in Q2 2021, an estimated $4.31M.
  • Rafferty Asset Management first reported a position in Q32 Bio in Q2 2019 and held it in 6 quarters.
  • Rafferty Asset Management's Q32 Bio position peaked at $4.31M in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2021.

Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.